Furthermore, evidence of BDM induced dyslipidemia had no effect on BBB dysfunction or neuroinflammation, most likely due to the protective effects of anti-inflammatory cytokines, or by an increase in other BDM bioactive compounds such as phospholipids, calcium and lactadherin. This evidence concerns the gene MFGE8 and metabolic syndrome.